Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation.

Immunity
Lai WeiYuka Kanno

Abstract

Signal transducer and activator of transcription 4 (STAT4) and STAT6 are key factors in the specification of helper T cells; however, their direct roles in driving differentiation are not well understood. Using chromatin immunoprecipitation and massive parallel sequencing, we quantitated the full complement of STAT-bound genes, concurrently assessing global STAT-dependent epigenetic modifications and gene transcription by using cells from cognate STAT-deficient mice. STAT4 and STAT6 each bound over 4000 genes with distinct binding motifs. Both played critical roles in maintaining chromatin configuration and transcription of a core subset of genes through the combination of different epigenetic patterns. Globally, STAT4 had a more dominant role in promoting active epigenetic marks, whereas STAT6 had a more prominent role in antagonizing repressive marks. Clusters of genes negatively regulated by STATs were also identified, highlighting previously unappreciated repressive roles of STATs. Therefore, STAT4 and STAT6 play wide regulatory roles in T helper cell specification.

References

Oct 31, 1996·Nature·A K AbbasA Sher
Mar 1, 1997·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·T DeckerA Meinke
Jun 13, 2000·Oncogene·A L WursterM J Grusby
Sep 5, 2002·Nature Reviews. Molecular Cell Biology·David E Levy, J E Darnell
Dec 4, 2002·Nature Reviews. Immunology·Kenneth M Murphy, Steven L Reiner
Jan 26, 2005·Immunology·Mai Wang, Peng Liang
Mar 23, 2006·Annual Review of Immunology·K Mark AnselAnjana Rao
Apr 19, 2006·Immunity·Gap Ryol LeeRichard A Flavell
Jun 20, 2006·Immunity·Casey T WeaverKenneth M Murphy
Oct 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Tae-Young RohKeji Zhao
Feb 27, 2007·Cell·Bradley E BernsteinEric S Lander
Apr 10, 2007·Cell·Steven L Reiner
Apr 19, 2007·Nature Immunology·César CobaledaMeinrad Busslinger
Sep 8, 2007·Trends in Molecular Medicine·Gang G WangPing Chi
Mar 26, 2008·Immunology and Cell Biology·Axel Kallies
May 31, 2008·Cell·Shimon SakaguchiMasahiro Ono
Jul 16, 2008·The Journal of Allergy and Clinical Immunology·Kiyoshi HiraharaToshinori Nakayama
Aug 8, 2008·Nucleic Acids Research·Raja JothiKeji Zhao
Aug 30, 2008·Blood·Jinfang Zhu, William E Paul
Nov 4, 2008·Nature Biotechnology·Hongkai JiWing H Wong
Jan 20, 2009·Nature Reviews. Immunology·Christopher B WilsonMasayuki Sekimata
Mar 24, 2009·Immunity·Nicolas FazilleauMichael G McHeyzer-Williams
May 26, 2009·Immunity·Liang ZhouDan R Littman
Oct 10, 2009·Trends in Genetics : TIG·Zeba Wunderlich, Leonid A Mirny

❮ Previous
Next ❯

Citations

Mar 29, 2011·Immunologic Research·Shreevrat Goenka, Mark H Kaplan
Mar 30, 2011·Immunology and Cell Biology·Rebeca JimenoYasmina Juarranz
Oct 15, 2010·Nature Biotechnology·Helai P Mohammad, Stephen B Baylin
Jan 11, 2011·Nature Immunology·Sabina A IslamAndrew D Luster
Nov 18, 2011·Nature Immunology·Michael A Farrar, Lynn M Heltemes Harris
Jul 4, 2012·Nature Immunology·Francisco J QuintanaVijay K Kuchroo
May 9, 2012·Nature Medicine·Sabina A Islam, Andrew D Luster
Mar 26, 2011·Nature Reviews. Immunology·John J O'SheaYuka Kanno
Jun 19, 2013·Proceedings of the National Academy of Sciences of the United States of America·Xingguang LiuXuetao Cao
Jul 14, 2010·The Journal of Biological Chemistry·Yi-Ching OngJohn C Boothroyd
Oct 29, 2010·The Journal of Biological Chemistry·Elisabeth MaierJutta Horejs-Hoeck
Sep 4, 2013·The Journal of Experimental Medicine·Sabina A IslamAndrew D Luster
Jul 24, 2013·Briefings in Functional Genomics·Catherine M Evans, Richard G Jenner
Oct 10, 2013·Briefings in Functional Genomics·Tapio LönnbergRiitta Lahesmaa
Dec 7, 2010·Nucleic Acids Research·Daniel HebenstreitSarah A Teichmann
Jan 9, 2013·Nucleic Acids Research·Andrew Paul HutchinsDiego Miranda-Saavedra
Jul 23, 2013·Nucleic Acids Research·Kelly Patrick StantonYuval Kluger
Jan 25, 2013·Open Biology·Stephanie M CoomesMark S Wilson
Jan 26, 2011·Molecular and Cellular Biology·Supriyo DeMichael J Pazin
May 21, 2011·American Journal of Respiratory and Critical Care Medicine·Ivana V Yang, David A Schwartz
Oct 2, 2012·Journal of Leukocyte Biology·Hoainam T Nguyen-JacksonStephanie S Watowich
Sep 17, 2013·PLoS Computational Biology·Anthony Mathelier, Wyeth W Wasserman
Jan 1, 2014·PloS One·Jonathan P RileyShreevrat Goenka
May 3, 2014·PloS One·Katarzyna WachowiczGottfried Baier
Nov 11, 2014·Nature Structural & Molecular Biology·Tomohiko KannoKeiko Ozato
Dec 10, 2013·BMC Genomics·Louise M BrignullAxel Nohturfft
Feb 11, 2014·Developmental and Comparative Immunology·Nolwenn M DheillyLouis Du Pasquier
Aug 26, 2014·Nature Communications·Anupama SahooRoza Nurieva
May 23, 2014·Expert Opinion on Therapeutic Targets·Yan LiangDong-Qing Ye
Jan 11, 2016·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Natsuki FukuokaTakao Kataoka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.